LATEST NEWS
For a full overview of our announcements and press releases, visit our Euronext Oslo Børs Newsweb (Link)
EXACT Therapeutics: Exercise of Warrants by GE Medical Holding AB
Positive initial safety read-out from the Phase 2 ENACT trial in pancreatic cancer, triggering option to exercise warrants
EXACT Therapeutics announces grant of core patent in the U.S.
EXACT Therapeutics announces first patient dosed in Phase 2 trial in patients with locally advanced pancreatic cancer
Wall Street Journal:
New Ultrasound Therapy Could Help Treat Alzheimer’s, Cancer

